HeartLung.AI
Listing Description
HeartLung.AI is a health-tech company aiming to bring AI-enabled early detection and prevention of cardiovascular disease and lung cancer to mass adoption. Additionally, the AI help physicians to opportunistically detect osteoporosis, fatty liver disease, and other cardiometabolic abnormalities such as myosteatosis. HeartLung Technologies Received FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™: The first AI that enables opportunistic detection of hidden heart disease in millions of chest CT scans. HeartLung cleared FDA 510(k) for AutoBMD which is the only DEXA-equivalent, CT-based opportunistic osteoporosis screening applicable to 25+ million CT scans of the chest and abdomen every year. HeartLung is awaiting approval for AI-CVD™ which includes multiple AI modules including AutoCAC™ (Automated Coronary Artery Calcium Scoring based on the legacy Agatston score) and AI-CAC ™ the new calcium scoring technique powered by AI, also referred to as “Agatston 2.0”. HeartLung is initially focused on opportunistic screening in chest CT scans as the lowest hanging fruit for preventive care. To use HeartLung.AI services no hardware or software installation is required—simply sign up within 5 minutes at www.provider.heartlung.ai and connect your PACS to HeartLung.AI cloud and receive AI-generated DICOMized PDF reports sent directly back to your PACS.
This seamless integration allows for immediate use without changing existing workflow. Additionally, referring physicians manually upload CT scans and receive instant AI-generated reports. Similar AI-CVD will empower hospitals and diagnostic imaging centers to provide their patients with fast, actionable data for multiple diseases all from a single chest CT scan.
HeartLung Technologies is positioned to lead the future of AI-enabled preventive imaging to fight the number 1 and 2 causes of death namely cardiovascular disease, and lung cancer. HeartLung’s innovations, including AI-CVD™, AI-CAC™, AutoChamber™, and AutoBMD™, are designed to empower hospitals and imaging centers with precision prevention technology at population scale.